Literature DB >> 29588680

AXXESS™ Stent: Delivery Indications and Outcomes.

John Rawlins1, Jehangir Din1, Suneel Talwar1, Peter O'Kane1.   

Abstract

The successful treatment of coronary bifurcation lesions remains one of the challenges of interventional cardiology. The current consensus of the European Bifurcation Club based on published data advocates a provisional strategy, treating the main vessel (MV) with a single stent covering the side branch (SB), with bailout SB stenting as required. The success of this approach may be limited by failure to attain SB access after MV stenting but is preferred in most situations over routine SB plus MV stent techniques, which are associated with a significant increase in the rate of major adverse cardiac events. The AXXESS self-expanding biolimus-eluting stent has been developed as a solution to these challenges within the coronary circulation and maintains provisional MV stent approach but with added assurance of maintained SB access. It has a unique conical structure that is positioned spanning the carina, with scaffold extending into the carina of both the MV and SB. The purpose of this article is to describe the indication, implantation technique and outcome data supporting the use of the AXXESS stent in the treatment of coronary bifurcation lesions.

Entities:  

Keywords:  AXXESS stent; bifurcation; biolimus; provisional; self-expanding

Year:  2015        PMID: 29588680      PMCID: PMC5808636          DOI: 10.15420/icr.2015.10.2.85

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  16 in total

1.  Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.

Authors:  Stephan Windecker; Patrick W Serruys; Simon Wandel; Pawel Buszman; Stanislaw Trznadel; Axel Linke; Karsten Lenk; Thomas Ischinger; Volker Klauss; Franz Eberli; Roberto Corti; William Wijns; Marie-Claude Morice; Carlo di Mario; Simon Davies; Robert-Jan van Geuns; Pedro Eerdmans; Gerrit-Anne van Es; Bernhard Meier; Peter Jüni
Journal:  Lancet       Date:  2008-08-31       Impact factor: 79.321

2.  Stent deformation, physical stress, and drug elution obtained with provisional stenting, conventional culotte and Tryton-based culotte to treat bifurcations: a virtual simulation study.

Authors:  Stefano Morlacchi; Claudio Chiastra; Elena Cutrì; Paolo Zunino; Francesco Burzotta; Luca Formaggia; Gabriele Dubini; Francesco Migliavacca
Journal:  EuroIntervention       Date:  2014       Impact factor: 6.534

3.  COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.

Authors:  Christophe Dubois; Johan Bennett; Joseph Dens; Dries De Cock; Walter Desmet; Ann Belmans; Giovanni J Ughi; Peter Sinnaeve; Mathias Vrolix; Jan D'hooge; Tom Adriaenssens
Journal:  EuroIntervention       Date:  2016-04-20       Impact factor: 6.534

4.  Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study.

Authors:  Miles W Behan; Niels R Holm; Nicholas P Curzen; Andrejs Erglis; Rodney H Stables; Adam J de Belder; Matti Niemelä; Nina Cooter; Derek P Chew; Terje K Steigen; Keith G Oldroyd; Jan S Jensen; Jens Flensted Lassen; Leif Thuesen; David Hildick-Smith
Journal:  Circ Cardiovasc Interv       Date:  2011-01-04       Impact factor: 6.546

5.  Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study.

Authors:  Ian Buysschaert; Christophe L Dubois; Joseph Dens; John Ormiston; Stephen Worthley; Dougal McClean; Jan Paul Ottervanger; Ian Meredith; Neal Uren; William Wijns; Rob Whitbourn; Roxana Mehran; Alexandra J Lansky; Marzena Bichalska; Susanne Meis; Stefan Verheye
Journal:  EuroIntervention       Date:  2013-09       Impact factor: 6.534

6.  Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation.

Authors:  Gaku Nakazawa; Saami K Yazdani; Aloke V Finn; Marc Vorpahl; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2010-04-20       Impact factor: 24.094

7.  Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.

Authors:  David Hildick-Smith; Adam J de Belder; Nina Cooter; Nicholas P Curzen; Tim C Clayton; Keith G Oldroyd; Lorraine Bennett; Steve Holmberg; James M Cotton; Peter E Glennon; Martyn R Thomas; Philip A Maccarthy; Andreas Baumbach; Niall T Mulvihill; Robert A Henderson; Simon R Redwood; Ian R Starkey; Rodney H Stables
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

8.  Classification of coronary artery bifurcation lesions and treatments: time for a consensus!

Authors:  Yves Louvard; Martyn Thomas; Vladimir Dzavik; David Hildick-Smith; Alfredo R Galassi; Manuel Pan; Francisco Burzotta; Michael Zelizko; Darius Dudek; Peter Ludman; Imad Sheiban; Jens F Lassen; Olivier Darremont; Adnan Kastrati; Josef Ludwig; Ioannis Iakovou; Philippe Brunel; Alexandra Lansky; David Meerkin; Victor Legrand; Alfonso Medina; Thierry Lefèvre
Journal:  Catheter Cardiovasc Interv       Date:  2008-02-01       Impact factor: 2.692

9.  9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.

Authors:  Stefan Verheye; Pierfrancesco Agostoni; Christophe L Dubois; Joseph Dens; John Ormiston; Stephen Worthley; Brett Trauthen; Takao Hasegawa; Bon-Kwon Koo; Peter J Fitzgerald; Roxana Mehran; Alexandra J Lansky
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

10.  Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings.

Authors:  Eberhard Grube; Lutz Buellesfeld; Franz J Neumann; Stefan Verheye; Alexandre Abizaid; Dougal McClean; Ralf Mueller; Alexandra Lansky; Roxana Mehran; Ricardo Costa; Ulrich Gerckens; Brett Trauthen; Peter J Fitzgerald
Journal:  Am J Cardiol       Date:  2007-05-07       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.